Ameritas Advisory Services’s Rockwell Medical RMTI Stock Holding History

Ameritas Advisory Services’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,056	Closed	-$54.2K	–	824
2023 Q2	$54.2K	Buy	+1,056	New	+$32.5K	0.01%	543

Other funds holding RMTI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Ameritas Advisory Services's RMTI Position: Q3 2023 in Review

Ameritas Advisory Services sold out of Rockwell Medical (RMTI) in Q3 2023, closing a stake of 1,056 shares — an estimated $54.2K sold.

Ameritas Advisory Services first reported a position in RMTI in Q2 2023 and held it in 1 quarter. The position peaked at $54.2K in Q2 2023. 32 funds tracked by Wall St. Rank hold RMTI as of Q3 2023.

Ameritas Advisory Services reported no remaining Rockwell Medical position as of Q3 2023 after selling out during the quarter.
Ameritas Advisory Services sold 1,056 Rockwell Medical shares in Q3 2023, an estimated $54.2K.
Ameritas Advisory Services first reported a position in Rockwell Medical in Q2 2023 and held it in 1 quarter.
Ameritas Advisory Services's Rockwell Medical position peaked at $54.2K in Q2 2023.
32 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2023.

Based on Ameritas Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.